## Abstract Levodopa (L‐dopa) and subthalamic nucleus (STN) stimulation treatments have been associated with both improvement and exacerbation of dysarthria in Parkinson's disease (PD). We report four cases illustrating variant responses of dysarthria to dopaminergic and STN stimulation therapies.
Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility
✍ Scribed by Marc Rousseaux; Pierre Krystkowiak; Odile Kozlowski; Canan Özsancak; Serge Blond; Alain Destée
- Book ID
- 106092393
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 258 KB
- Volume
- 251
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv
## Abstract Subthalamic nucleus deep brain stimulation (STN‐DBS) is particularly effective in improving limb symptoms in Parkinson's disease. However, speech shows a variable response. Contact site and amplitude of stimulation have been suggested as possible factors influencing speech. In this doub
## Abstract Inconsistent response in freezing of gait (FOG) with levodopa treatment or STN DBS makes the pathogenesis difficult to understand. We studied brain areas associated with the expression of STN DBS effect on parkinsonian motor deficits and FOG. Ten Parkinson's disease patients with typica